Oncology Center Of Excellence Deputy Directors Kluetz, Theoret Join US FDA Exodus

 
• By Sue Sutter and Sarah Karlin-Smith

The April departures of Paul Kluetz and Marc Theoret follow resignations by other senior agency scientific staff and come on top of HHS’ plans to lay off 3,500 FDA employees.

Exit sign
Voluntary departures are adding to the loss due to layoffs, early retirements and buyouts. (Shutterstock)

More from US FDA

More from Agency Leadership